tiprankstipranks
Cidara Therapeutics reports Q3 EPS ($2.45), consensus ($4.25)
PremiumThe FlyCidara Therapeutics reports Q3 EPS ($2.45), consensus ($4.25)
1M ago
Cidara Therapeutics reports Q3 EPS ($2.45), consensus ($4.25)
Premium
The Fly
Cidara Therapeutics reports Q3 EPS ($2.45), consensus ($4.25)
1M ago
Is CDTX a Buy, Before Earnings?
Premium
Pre-Earnings
Is CDTX a Buy, Before Earnings?
2M ago
Cidara Therapeutics trading resumes
PremiumThe FlyCidara Therapeutics trading resumes
3M ago
Cidara Therapeutics to reduce workforce by 30%, to focus on CD388 development
Premium
The Fly
Cidara Therapeutics to reduce workforce by 30%, to focus on CD388 development
3M ago
Cidara Therapeutics trading halted, news pending
Premium
The Fly
Cidara Therapeutics trading halted, news pending
3M ago
Cidara Therapeutics Shareholders Decide on Key Corporate Changes
PremiumCompany AnnouncementsCidara Therapeutics Shareholders Decide on Key Corporate Changes
5M ago
Cidara Therapeutics CEO buys $105.7K in common stock
Premium
The Fly
Cidara Therapeutics CEO buys $105.7K in common stock
6M ago
Cidara Therapeutics Inc. Hits Snag: Delayed 10-K Filing Complicates Capital Raising Efforts
Premium
Company Announcements
Cidara Therapeutics Inc. Hits Snag: Delayed 10-K Filing Complicates Capital Raising Efforts
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100